Printer Friendly

TELIOS ANNOUNCES MANAGEMENT CHANGE

 SAN DIEGO, Jan. 4 /PRNewswire/ -- Telios Pharmaceuticals Inc. (NASDAQ: TLIO) today announced that Robert J. Erickson, Ph.D., had resigned as president and chief executive officer for health reasons. The board of directors regretfully accepted his resignation from these positions and noted with appreciation his contributions made to building the company over the last six years. Erickson will remain a member of Telios' board of directors.
 The company's chairman and one of its founders, Theodor H. Heinrichs, has reassumed the position of chief executive officer until a successor to Erickson can be found. Heinrichs had been the company's chief executive officer from its founding through 1991. Heinrichs, an international executive with more than 35 years experience in the pharmaceutical industry, was formerly chairman, president, and chief executive officer of Cutter Laboratories and chairman and chief executive officer of Miles Laboratories, both units of Bayer A.G. Since 1985, Heinrichs has been general partner of H&Q Life Science Ventures.
 Telios is a leader in the development of "matrix medicine" -- a new class of therapeutic products that modify or mimic extracellular matrix functions in tissue repair and disease. Telios is applying its proprietary technology to develop products for the treatment of severe and chronic dermal wounds, ophthalmic wounds, fibrotic diseases (such as certain kidney, liver, and lung diseases), cardiovascular diseases, and osteoporosis.
 -0- 1/4/94
 /CONTACT: David Duncan Jr., CFO of Telios Pharmaceuticals, 619-622-2615/
 (TLIO)


CO: Telios Pharmaceuticals Inc. ST: California IN: MTC SU: PER

JB-LS -- SD004 -- 9065 01/04/94 17:31 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 4, 1994
Words:254
Previous Article:JONES APPAREL GROUP, INC. REGISTERS WITH SEC FOR PUBLIC OFFERING OF 3,100,000 SECONDARY SHARES OF COMMON STOCK
Next Article:3DO PLANS TO SHOWCASE SOFTWARE AT CES; 18 TITLES CURRENTLY IN STORES FOR 3DO SYSTEM
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters